DZ Bank’s Alder Biopharmaceuticals ALDR Stock Holding History

DZ Bank’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-124,900	Closed	-$1.59M	–	1179
2018 Q1	$1.59M	Buy	+124,900	New	+$1.81M	0.01%	587

Other funds holding ALDR

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DZ Bank's ALDR Position: Q2 2018 in Review

DZ Bank sold out of Alder Biopharmaceuticals (ALDR) in Q2 2018, closing a stake of 124,900 shares — an estimated $1.59M sold.

DZ Bank first reported a position in ALDR in Q1 2018 and held it in 1 quarter. The position peaked at $1.59M in Q1 2018. 139 funds tracked by Wall St. Rank hold ALDR as of Q2 2018.

DZ Bank reported no remaining Alder Biopharmaceuticals position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 124,900 Alder Biopharmaceuticals shares in Q2 2018, an estimated $1.59M.
DZ Bank first reported a position in Alder Biopharmaceuticals in Q1 2018 and held it in 1 quarter.
DZ Bank's Alder Biopharmaceuticals position peaked at $1.59M in Q1 2018.
139 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.